- Home
- CISO vs SBFM Comparison
CISO vs SBFM Comparison
Compare CISO & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- SBFM
- Stock Information
- Founded
- CISO 2015
- SBFM 2006
- Country
- CISO United States
- SBFM United States
- Employees
- CISO N/A
- SBFM N/A
- Industry
- CISO Computer Software: Prepackaged Software
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- CISO Technology
- SBFM Health Care
- Exchange
- CISO Nasdaq
- SBFM Nasdaq
- Market Cap
- CISO 31.4M
- SBFM 6.7M
- IPO Year
- CISO N/A
- SBFM N/A
- Fundamental
- Price
- CISO $0.97
- SBFM $1.51
- Analyst Decision
- CISO
- SBFM Strong Buy
- Analyst Count
- CISO 0
- SBFM 1
- Target Price
- CISO N/A
- SBFM $15.00
- AVG Volume (30 Days)
- CISO 885.5K
- SBFM 192.4K
- Earning Date
- CISO 08-13-2025
- SBFM 08-15-2025
- Dividend Yield
- CISO N/A
- SBFM N/A
- EPS Growth
- CISO N/A
- SBFM N/A
- EPS
- CISO N/A
- SBFM N/A
- Revenue
- CISO $29,887,603.00
- SBFM $36,234,578.00
- Revenue This Year
- CISO N/A
- SBFM $192.48
- Revenue Next Year
- CISO N/A
- SBFM N/A
- P/E Ratio
- CISO N/A
- SBFM N/A
- Revenue Growth
- CISO N/A
- SBFM 35.51
- 52 Week Low
- CISO $0.26
- SBFM $1.17
- 52 Week High
- CISO $3.84
- SBFM $6.99
- Technical
- Relative Strength Index (RSI)
- CISO 39.86
- SBFM 49.86
- Support Level
- CISO $1.16
- SBFM $1.43
- Resistance Level
- CISO $1.24
- SBFM $1.61
- Average True Range (ATR)
- CISO 0.09
- SBFM 0.12
- MACD
- CISO -0.03
- SBFM 0.00
- Stochastic Oscillator
- CISO 0.12
- SBFM 32.78
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.